Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Modus Therapeutics AB

Home Clinical Trial Sponsors and OrganizationsModus Therapeutics AB

Modus Therapeutics AB

ACTIVE

Sankt Eriksgatan 117, Stockholm, Swedenwww.modustx.comPublic1–10 employeesEstablished: 2011-01-01

Part of Modus Therapeutics Holding AB

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

7

2 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

2011

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

4

57.1%

Phase 2

3

42.9%

Trial Status Distribution

Active, not recruiting

2

28.6%

Completed

3

42.9%

Recruiting

1

14.3%

Terminated

1

14.3%

Clinical Trials

Trials sponsored by this organization (7)

Placebo-controlled Study to Determine the Safety and Tolerability of Subcutaneous Doses of Sevuparin

Feb 201924 participants

A Study to Explore Sevuparin Infusion for the Management of Acute Vaso-Occlusive Crisis (VOC) in Subjects with Sickle-Cell Disease (SCD)

Active, not recruiting

Sep 2018133 participants

Sevuparin Infusion for the Management of Acute VOC in Subjects With SCD

Jul 2015147 participants

A Study to Explore Sevuparin Infusion for the Management of Acute Vaso-Occlusive Crisis (VOC) in Subjects with Sickle-Cell Disease (SCD)

Active, not recruiting

Apr 2015133 participants

Sevuparin/DF02 as an Adjunctive Therapy in Subjects Affected With Uncomplicated Falciparum Malaria

Sep 201153 participants

A Phase II Study with Sevuparin in Subjects with Chronic Kidney Disease

60 participants

A multi-centre, phase II, randomized, double-blind, placebo-controlled study to investigate efficacy and safety of sevuparin infusion for the management of acute vaso-occlusive crisis (VOC) in subjects with sickle-cell disease (SCD)

30 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials7
Approvals
News

Back to Organizations